Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypericum perforatum and Its Ingredients Hypericin and Pseudohypericin Demonstrate an Antiviral Activity against SARS-CoV-2
Fakry F. Mohamed, Darisuren Anhlan, Michael Schöfbänker, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 530-530
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Boosting the human antiviral response in conjunction with natural plant products
Rashmi Srivastava, Neeraj Kumar Dubey, Megha Sharma, et al.
Frontiers in Natural Products (2025) Vol. 3
Open Access | Times Cited: 2
Hypericin: A natural anthraquinone as promising therapeutic agent
Jingjing Wu, Jia Zhang, Cong‐Yuan Xia, et al.
Phytomedicine (2023) Vol. 111, pp. 154654-154654
Closed Access | Times Cited: 26
Recent advances in the discovery of plant-derived antimicrobial natural products to combat antimicrobial resistant pathogens: insights from 2018–2022
Sunmin Woo, Lewis Marquez, William J. Crandall, et al.
Natural Product Reports (2023) Vol. 40, Iss. 7, pp. 1271-1290
Closed Access | Times Cited: 24
The potential role of Hypericum perforatum in wound healing: A literature review on the phytochemicals, pharmacological approaches, and mechanistic perspectives
Bahareh Farasati Far, Ghazaleh Gouranmohit, Mohammad Reza Naimi‐Jamal, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 7, pp. 3271-3295
Closed Access | Times Cited: 10
Medicinal Herbs in the Relief of Neurological, Cardiovascular, and Respiratory Symptoms after COVID-19 Infection A Literature Review
Joanna Nawrot, Justyna Gornowicz‐Porowska, Jaromir Budzianowski, et al.
Cells (2022) Vol. 11, Iss. 12, pp. 1897-1897
Open Access | Times Cited: 34
Cannabigerol and Cannabicyclol Block SARS-CoV-2 Cell Fusion
Nica Classen, Thanet Pitakbut, Michael Schöfbänker, et al.
Planta Medica (2024) Vol. 90, Iss. 09, pp. 717-725
Closed Access | Times Cited: 5
In vivo and in vitro, antiviral effects of two mixture of Chinese herbal drug active monomers against MSRV and LMBV in largemouth bass (Micropterus salmoides)
Yinjie Niu, Xiaozhe Fu, Qiang Lin, et al.
Aquaculture (2023) Vol. 577, pp. 739977-739977
Closed Access | Times Cited: 13
Progress in Research on Inhibitors Targeting SARS-CoV-2 Main Protease (Mpro)
Yue Yang, Yidan Luo, Chenbo Zhang, et al.
ACS Omega (2024) Vol. 9, Iss. 32, pp. 34196-34219
Open Access | Times Cited: 3
Strategies for the Management of Spike Protein-Related Pathology
Matthew Halma, Christof Plothe, Paul E. Marik, et al.
Microorganisms (2023) Vol. 11, Iss. 5, pp. 1308-1308
Open Access | Times Cited: 9
Hypericum perforatum L. and the Underlying Molecular Mechanisms for Its Choleretic, Cholagogue, and Regenerative Properties
Ala Mohagheghzadeh, Parmis Badr, Abdolali Mohagheghzadeh, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 887-887
Open Access | Times Cited: 6
Hypericin as a promising natural bioactive naphthodianthrone: A review of its pharmacology, pharmacokinetics, toxicity, and safety
Zhaolei Peng, Jing Lu, Kai Liu, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 12, pp. 5639-5656
Closed Access | Times Cited: 6
Variant-specific humoral immune response to SARS-CoV-2 escape mutants arising in clinically severe, prolonged infection
Theresa Günther, Michael Schöfbänker, Eva U. Lorentzen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Antiviral activity of natural compounds extracted from Mediterranean medicinal plants against SARS-CoV-2
Stephanie Ghio, Jean‐Pierre Brincat, Yüksel Çetin, et al.
Academia Biology (2024) Vol. 2, Iss. 3
Open Access | Times Cited: 1
Insights for Future Pharmacology: Exploring Phytochemicals as Potential Inhibitors Targeting SARS-CoV-2 Papain-like Protease
Jawaria Jabeen, Nabeel Ahmed, Zunaira Shahzad, et al.
Future Pharmacology (2024) Vol. 4, Iss. 3, pp. 510-540
Open Access | Times Cited: 1
Die Bedeutung von Antidepressiva bei COVID-19 und Long-COVID – Ein Scoping-Review Update
Udo Bonnet, Georg Juckel
Fortschritte der Neurologie · Psychiatrie (2024)
Closed Access | Times Cited: 1
Broadly Applicable, Virus-Free Dual Reporter Assay to Identify Compounds Interfering with Membrane Fusion: Performance for HSV-1 and SARS-CoV-2
Nica Classen, Diana Ulrich, Arne D. Hofemeier, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1354-1354
Open Access | Times Cited: 6
Biochemical Analyses of Bioactive Extracts from Plants Native to Lampedusa, Sicily Minor Island
Roberta Di Lecce, Natacha Mérindol, Mayra Galarza Pérez, et al.
Plants (2022) Vol. 11, Iss. 24, pp. 3447-3447
Open Access | Times Cited: 6
Strategies for the Management of Spike Protein-Related Pathology
Matthew Halma, Cristof Plothe, Theresa A Lawrie
(2023)
Open Access | Times Cited: 3
Multi-structural molecular docking (MOD) combined with molecular dynamics reveal the structural requirements of designing broad-spectrum inhibitors of SARS-CoV-2 entry to host cells
Anqi Da, Meritxell Wu‐Lu, Jovan Dragelj, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Promising role of Vitamin D and plant metabolites against COVID-19: Clinical trials review
Rupanshee Srivastava, Nidhi Singh, Tripti Kanda, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21205-e21205
Open Access | Times Cited: 3
Surrogate Virus Neutralisation Test Based on Nanoluciferase-Tagged Antigens to Quantify Inhibitory Antibodies against SARS-CoV-2 and Characterise Omicron-Specific Reactivity in a Vaccination Cohort
Michael Schoefbaenker, Rieke Neddermeyer, Theresa Guenther, et al.
Vaccines (2023) Vol. 11, Iss. 12, pp. 1832-1832
Open Access | Times Cited: 3
Production, Characterization, and In Vitro and In Vivo Studies of Nanoemulsions Containing St. John’s Wort Plant Constituents and Their Potential for the Treatment of Depression
Ahmad Salawi, Yosif Almoshari, Muhammad H. Sultan, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 490-490
Open Access | Times Cited: 2
Investigation of the inhibitory activity of extracts, fractions and secondary metabolites of <i>Silene</i> spp. (<i>Caryophyllaceae</i>) and <i>Serratula cupuliformis</i> (<i>Asteraceae</i>) on the replication of SARS-CoV-2 coronavirus
E I Kazachinskaia, Л. Н. Зибарева, Е. С. Филоненко, et al.
South of Russia ecology development (2023) Vol. 18, Iss. 1, pp. 62-81
Open Access | Times Cited: 2
Inhibitory activity of dry ethanol extracts of <i>Artemisia</i> spp. on SARS‐CoV‐2 replication <i>in vitro</i>
E I Kazachinskaia, Valeriya Romanova, A. V. Ivanоva, et al.
South of Russia ecology development (2022) Vol. 17, Iss. 4, pp. 111-129
Open Access | Times Cited: 4
Major Metabolites fromHypericum PerforatumL., Hyperforin and Hypericin, are both active against Human Coronaviruses
Imelda Raczkiewicz, Céline Rivière, Peggy Bouquet, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1 - Next Page

Scroll to top